Clinical Trial Update: TocILizumab in aorTitis in GCA (TILT)

View source ↗

Summary

Clinical trial update for the TILT study evaluating tocilizumab for aortitis in giant cell arteritis (GCA); the trial is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aortitis
• Giant Cell Arteritis

Drugs mentioned

• Tocilizumab (tocilizumab)

Snippet

Sponsor: Groupe français d'étude des Maladies Inflammatoires de loeil | Conditions: Aortitis, Giant Cell Arteritis (GCA) | Status: RECRUITING